Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(7 sites)
Canada
University of Calgary, Calgary, Alberta University of Alberta, Edmonton, Alberta Vancouver General Hospital, Vancouver, British Columbia St. Paul's Hospital, Vancouver, British Columbia The Ottawa Hospital, Ottawa, Ontario Toronto General Hospital, Toronto, Ontario Women's College Hospital, Toronto, Ontario Age range
18 Years and older
Last updated February 2025